Elizabeth Amoaa named ambassador for ENDO1000 Project

Elizabeth Amoaa, a distinguished women’s health advocate and trailblazer popularly known as Special Lady, has been named an ambassador for the ENDO1000 Project. In this role, she brings her voice, lived experience, and vision to a groundbreaking research initiative that seeks to improve health outcomes and offer renewed hope to those living with endometriosis.

The ENDO1000 Project, led by Professor Andrew Horne at the University of Edinburgh’s Institute for Regeneration and Repair, is one of the most ambitious studies ever undertaken in the field of endometriosis research. The initiative aims to recruit 1,000 individuals diagnosed with endometriosis and follow them over two years, collecting an extensive range of biological and real-world data.

By combining patient-reported information, wearable technology, and biological samples, the project seeks to address long-standing gaps in diagnosis, treatment, and personalised care for a condition that affects millions worldwide.

Endometriosis impacts around 1 in 10 people assigned female at birth, yet diagnosis can often take years. Current treatments tend to be generic rather than tailored, and limited understanding of how genetics, environment, and lifestyle intersect further complicates care.

By leveraging digital health tools, biological sciences, and machine learning, ENDO1000 represents a potential turning point in how the condition is understood. Its findings could empower clinicians, shape health policies, and most importantly, transform the lives of patients.

Elizabeth Amoaa has long been recognised for her bold advocacy and innovative approach to women’s health issues. Through her work, she has challenged taboos, redefined narratives, and created new spaces for dialogue on gynaecological conditions that are often overlooked.

As an ambassador for ENDO1000, she embodies the project’s mission to centre research on people, voices, and lived experiences. Her involvement highlights the human dimension of science—bridging world-class research with the communities it seeks to serve.

Elizabeth is the founder of Speciallady Awareness NGO in Ghana and Speciallady Awareness Global in the UK. With her influence and commitment, she continues to spotlight endometriosis as a global health priority while advancing solutions that could reshape the future of care.

For more information on the project, visit www.endo1000.com